Telethon Institute of Genetics and Medicine (TIGEM), Via P. Castellino 111, 80131 Naples, Italy.
Dev Cell. 2011 Sep 13;21(3):421-30. doi: 10.1016/j.devcel.2011.07.016. Epub 2011 Sep 1.
Lysosomes are cellular organelles primarily involved in degradation and recycling processes. During lysosomal exocytosis, a Ca²⁺-regulated process, lysosomes are docked to the cell surface and fuse with the plasma membrane (PM), emptying their content outside the cell. This process has an important role in secretion and PM repair. Here we show that the transcription factor EB (TFEB) regulates lysosomal exocytosis. TFEB increases the pool of lysosomes in the proximity of the PM and promotes their fusion with PM by raising intracellular Ca²⁺ levels through the activation of the lysosomal Ca²⁺ channel MCOLN1. Induction of lysosomal exocytosis by TFEB overexpression rescued pathologic storage and restored normal cellular morphology both in vitro and in vivo in lysosomal storage diseases (LSDs). Our data indicate that lysosomal exocytosis may directly modulate cellular clearance and suggest an alternative therapeutic strategy for disorders associated with intracellular storage.
溶酶体是主要参与降解和回收过程的细胞细胞器。在溶酶体胞吐作用(Ca²⁺调节过程)期间,溶酶体与细胞膜表面对接并与质膜(PM)融合,将其内容物排空到细胞外。这个过程在分泌和 PM 修复中起着重要作用。在这里,我们表明转录因子 EB(TFEB)调节溶酶体胞吐作用。TFEB 通过激活溶酶体 Ca²⁺通道 MCOLN1 增加 PM 附近溶酶体的池,并通过提高细胞内 Ca²⁺水平促进它们与 PM 的融合。TFEB 过表达诱导的溶酶体胞吐作用可挽救病理性储存,并在体外和体内溶酶体储存疾病(LSD)中恢复正常细胞形态。我们的数据表明,溶酶体胞吐作用可能直接调节细胞清除,并为与细胞内储存相关的疾病提供了一种替代的治疗策略。